10/9/2026
FDA seeks input on ibogaine trials amid safety concerns
FDA's request for ibogaine trial proposals highlights cardiac risks and regulatory challenges.
Topic archive
heidi overton
6 stories
10/9/2026
FDA faces internal dissent over HHS peptide legalization
HHS plans to allow unapproved peptides, sparking FDA staff concerns.
8/20/2026
Trump's FDA pick linked to Joe Rogan-backed psychedelic policy
Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.
8/19/2026
Trump's FDA pick Overton may boost psychedelics, pain meds
Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.